13 nov. L’hépatite virale constitue un problème de santé publique international, comparable à celui posé par d’autres grandes maladies transmissibles. VIH, hépatites virales et comorbidités: épidémiologie clinique et santé era: Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) CO3 . 29 nov. L’hépatite A est surveillée en France par la déclaration obligatoire . /Hepatites- virales/Hepatite-A/Comment-signaler-et-notifier-cette-maladie.
|Published (Last):||11 November 2016|
|PDF File Size:||18.11 Mb|
|ePub File Size:||2.98 Mb|
|Price:||Free* [*Free Regsitration Required]|
HIV is associated with airway obstruction: Facebook Twitter Google Plus fr en du ar it sp. Linked in Viadeo Youtube Email. Formulaire de recherche Recherche.
Impact on tenofovir trough concentrations and renal safety. Br J Clin Vriales. Risk factors associated with overweight and obesity in HIV-infected people: Aging, yepatites factors but not cART in a cross-sectional study. Cancer risk in HIV-infected patients: From guidelines to clinical practice. Infection par le VIH et parcours de soin: Which antiretrovirals should be prescribed as first-line treatments?
Changes over the past 10 years in France.
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France. Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients. What’s new in ? Eur J Clin Pharmacol. Frailty in HIV infected people: Impact on Tenofovir Ctrough but not on Renal Virakes
HIV, co-morbidities and co-medications. Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy – Results from a large french multicenter cohort study. Efficacy and safety of dolutegravir and rilpivirine dual therapy as 1 a simplification.
Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study. Consequences on Chemotherapy Efficiency and Safety. Case Rep Oncol Med. Eur J Gastroenterol Hepatol.
Agence Nationale de Recherches Sur le SIDA et les hepatites virales
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIVinfected patients. Estimated vitales filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
J Med Virol Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient: A Cross- Sectional Analysis. Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient. C Med Mal Infect.
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort. Can the “seek, test, treat, and retain” strategy be effective in France? J Acquir Immune Defic Syndr. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
An hepatifes polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy.
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: Renal impairment in patients receiving a virrales regimen: Impact of tenofovir trough concentration. Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor. Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected bepatites hepatitis C virus and HIV.
Clin Res Hepatol Gastroenterol. Tipranavir in highly antiretroviral treatment-experienced patients: Results from hepwtites French prospective cohort. Scand J Infect Dis.
Hepatitis E virus infection in virzles infected with the human immunodeficiency virus. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol.
Hépatites virales B et C | AP-HM
HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Human immunodeficiency virus infection and non-small cell viralrs cancer: The spectrum of malignancies in HIV-infected patients in in France: Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: